Seeking Alpha

Biotech Analysis Central Model 10+ Portfolio Pick #1 Aldeyra Therapeutuics; NDA Resubmission Reproxalap Plus Phase 2 Data Alcoholic Hepatitis 2nd Half Of 2024, Cash Beyond 2026 ...

The next article I wanted to discuss for the Biotech Analysis Central Model 10+ Portfolio Pick #1 is a biotech by the name of Aldeyra Therapeutics (ALDX). The reason why i want to go over this biotech ...
Seeking Alpha

Biotech Analysis Central Model 10+ Portfolio #5 Cytokinetics; NMPA And FDA Approvals MYQORZO oHCM, Data For nHCM Same Drug Q2 2026, 1st Half 2026 EMA Approval Aficamten oHCM ...

The next article I wanted to discuss for the Biotech Analysis Central Model 10+ Portfolio Pick #5 is about a biotech by the name of Cytokinetics (CYTK). The reason why I believe that it is important ...